4//SEC Filing
Edge Therapeutics, Inc. 4
Accession 0001127602-17-002309
$PDSBCIK 0001472091operating
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 9:35 AM ET
Size
6.8 KB
Accession
0001127602-17-002309
Insider Transaction Report
Form 4
Macdonald R. Loch
DirectorChief Scientific Officer
Transactions
- Exercise/Conversion
Stock Option (right To Purchase)
2017-01-23−25,000→ 75,504 totalExercise: $2.04Exp: 2023-10-11→ Common Stock (25,000 underlying) - Exercise/Conversion
Common Stock
2017-01-23$2.04/sh+25,000$51,000→ 595,602 total
Footnotes (1)
- [F1]This option, representing a right to purchase a total of 100,504 shares of Common Stock, became exercisable on June 1, 2014, with 25% vesting on that date and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date.
Documents
Issuer
Edge Therapeutics, Inc.
CIK 0001472091
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001472091
Filing Metadata
- Form type
- 4
- Filed
- Jan 24, 7:00 PM ET
- Accepted
- Jan 25, 9:35 AM ET
- Size
- 6.8 KB